Sp33
WHAT DO YOU WHEN THE FORMULA SHELVES ARE BARE
Date
May 6, 2023
Explore related products in the following collection:
Society: AGA
There have been numerous times in the past few years wherein natural or man-made disasters have impacted the production and supply chain of key constituents of both enteral and parenteral nutrition products. These have impacted individuals on total parenteral nutrition (TPN) and on tube feeds or children/infants that are exclusively fed formula or suffer from metabolic or allergic disorders that necessitate them being on certain medical foods/specialty formula. As a community gastroenterolgists have been asked to step up in these situations to advocate for and construct disaster management plans. Through this session we would like to raise awareness for these general issues and provide state of the art guidance for these specific issues pertinent to daily clinical practice. LIVE STREAM SESSION
There have been numerous times in the past few years wherein natural or man-made disasters have impacted the production and supply chain of key constituents of both enteral and parenteral nutrition products. These have impacted individuals on total parenteral nutrition (TPN) and on tube feeds or children/infants that are exclusively fed formula or suffer from metabolic or allergic disorders that necessitate them being on certain medical foods/specialty formula. As a community gastroenterolgists have been asked to step up in these situations to advocate for and construct disaster management plans. Through this session we would like to raise awareness for these general issues and provide state of the art guidance for these specific issues pertinent to daily clinical practice. LIVE STREAM SESSION
Presenter
Tracks
Related Products
Q&A
There have been numerous times in the past few years wherein natural or man-made disasters have impacted the production and supply chain of key constituents of both enteral and parenteral nutrition products…
ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PRA023 AS INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: ARTEMIS-UC, COHORT 1
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
